Khalid Sossey-Alaoui
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Khalid Sossey-Alaoui has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- John K. Cowell
Georgia Cancer Center, Augusta University, Augusta, Georgia.
7 shared publications Xiurong Li
Department of Cancer Genetics, Roswell Park Cancer Institute, Elm and Carlton Streets, Buffalo, NY 14263, USA
6 shared publications- Andrei V. Bakin
Department of Genetics and Genomics Roswell Park Comprehensive Cancer Center Buffalo New York USA
3 shared publications Tamara A. Ranalli
Department of Cancer Genetics, Roswell Park Cancer Institute, Elm and Carlton Streets, Buffalo, NY 14263, USA
3 shared publicationsAlfiya Safina
Department of Cancer Genetics, Roswell Park Cancer Institute, Buffalo, New York
1 shared publicationDavid G. Hicks
Department of Pathology, Roswell Park Cancer Institute, Buffalo, New York
1 shared publication
Latest Publications
- 10 March 2013
- Published by Elsevier in Experimental Cell Research
- Vol. 319 (5) , 775
Corrigendum to “WAVE3 promotes cell motility and invasion through the regulation of MMP-1, MMP-3, and MMP-9 expression” [Exp. Cell Res. 308 (2005) 135–145]
- 10 March 2013
- Published by Elsevier in Experimental Cell Research
- Vol. 319 (5) , 775
Corrigendum to “WAVE3 promotes cell motility and invasion through the regulation of MMP-1, MMP-3, and MMP-9 expression” [Exp. Cell Res. 308 (2005) 135–145]
- Open Access
- 1 September 2007
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 282 (36) , 26257-26265
c-Abl-mediated Phosphorylation of WAVE3 Is Required for Lamellipodia Formation and Cell Migration
- 1 September 2007
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 282 (36) , 26257-26265
Open Accessc-Abl-mediated Phosphorylation of WAVE3 Is Required for Lamellipodia Formation and Cell Migration
- 1 June 2007
- Published by Elsevier in The American Journal of Pathology
- Vol. 170 (6) , 2112-2121
Down-Regulation of WAVE3, a Metastasis Promoter Gene, Inhibits Invasion and Metastasis of Breast Cancer Cells
- 1 June 2007
- Published by Elsevier in The American Journal of Pathology
- Vol. 170 (6) , 2112-2121
Down-Regulation of WAVE3, a Metastasis Promoter Gene, Inhibits Invasion and Metastasis of Breast Cancer Cells
- 1 August 2005
- Published by Elsevier in Experimental Cell Research
- Vol. 308 (1) , 135-145
WAVE3 promotes cell motility and invasion through the regulation of MMP-1, MMP-3, and MMP-9 expression
- 1 August 2005
- Published by Elsevier in Experimental Cell Research
- Vol. 308 (1) , 135-145
WAVE3 promotes cell motility and invasion through the regulation of MMP-1, MMP-3, and MMP-9 expression
- Open Access
- 1 June 2005
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 280 (23) , 21748-21755
WAVE3-mediated Cell Migration and Lamellipodia Formation Are Regulated Downstream of Phosphatidylinositol 3-Kinase
- 1 June 2005
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 280 (23) , 21748-21755
Open AccessWAVE3-mediated Cell Migration and Lamellipodia Formation Are Regulated Downstream of Phosphatidylinositol 3-Kinase
- 19 February 2004
- Published by Springer Nature in Oncogene
- Vol. 23 (7) , 1474-1480
CLCA2 tumour suppressor gene in 1p31 is epigenetically regulated in breast cancer
The calcium-activated chloride channel gene family is clustered in the 1p31 region, which is frequently deleted in sporadic breast cancer. Recent studies have indicated the association of the second member of this gene family (CLCA2) with the development of breast cancer and metastasis. We have now shown the absence of expression of CLCA2 in several breast cancer tumours and cell lines, which confirms the results from other reports. When overexpressed in CLCA2-negative cell lines, their tumorigenicity and metastasis capability were significantly reduced, suggesting a tumour suppressor role for CLCA2 in breast cancer. The mechanisms behind the silencing of CLCA2 in breast cancer, however, have not been elucidated to date. Although we were able to identify CLCA2 mutations in breast cancers, somatic mutations are not the major cause of CLCA2 gene silencing. On the other hand, treatment of breast cancer CLCA2-negative cell lines with demethylating agents was able to restore CLCA2 expression, suggesting an epigenetic inactivation of this gene. Bisulphite-sequencing of the promoter-associated CpG island of the CLCA2 gene in breast tumours demonstrated that the absence of expression in these tumours was caused by hypermethylation of the promoter CpG island. In contrast, in breast cancer cell lines, tumours, and control cell lines that express CLCA2, a much lower level, and often absence, of methylation of the promoter were demonstrated. These findings demonstrate that CLCA2 is frequently inactivated in breast cancer by promoter region hypermethylation, which makes it an excellent candidate for the 1p31 breast cancer tumour suppressor gene.
- 19 February 2004
- Published by Springer Nature in Oncogene
- Vol. 23 (7) , 1474-1480
CLCA2 tumour suppressor gene in 1p31 is epigenetically regulated in breast cancer
The calcium-activated chloride channel gene family is clustered in the 1p31 region, which is frequently deleted in sporadic breast cancer. Recent studies have indicated the association of the second member of this gene family (CLCA2) with the development of breast cancer and metastasis. We have now shown the absence of expression of CLCA2 in several breast cancer tumours and cell lines, which confirms the results from other reports. When overexpressed in CLCA2-negative cell lines, their tumorigenicity and metastasis capability were significantly reduced, suggesting a tumour suppressor role for CLCA2 in breast cancer. The mechanisms behind the silencing of CLCA2 in breast cancer, however, have not been elucidated to date. Although we were able to identify CLCA2 mutations in breast cancers, somatic mutations are not the major cause of CLCA2 gene silencing. On the other hand, treatment of breast cancer CLCA2-negative cell lines with demethylating agents was able to restore CLCA2 expression, suggesting an epigenetic inactivation of this gene. Bisulphite-sequencing of the promoter-associated CpG island of the CLCA2 gene in breast tumours demonstrated that the absence of expression in these tumours was caused by hypermethylation of the promoter CpG island. In contrast, in breast cancer cell lines, tumours, and control cell lines that express CLCA2, a much lower level, and often absence, of methylation of the promoter were demonstrated. These findings demonstrate that CLCA2 is frequently inactivated in breast cancer by promoter region hypermethylation, which makes it an excellent candidate for the 1p31 breast cancer tumour suppressor gene.
- 1 May 2003
- Published by Springer Nature in Mammalian Genome
- Vol. 14 (5) , 314-322
Genomic organization and expression profile of the human and mouse WAVE gene family
The WAVE gene family, which contains three members, has been shown to play a major role in the actin polymerization and cytoskeleton organization processes. We have identified the WAVE3 gene from Chromosome (Chr) 13q12, as being involved in one of the breakpoints of a t(1:13)(q21:q12) reciprocal translocation, in a patient with ganglioneuroblastoma (Sossey-Alaoui et al. 2002; Oncogene 21: 5967–5974). We have also reported the cloning of the mouse Wave3. During our analysis of the human gene map, we also noted that WAVE2 maps to Chr region lp35-36, which frequently undergoes loss of heterozygosity and deletion in advanced stage neuroblastoma. These data clearly indicate a possible involvement of the WAVE genes in the pathogenesis of neuroblastoma. In this study, we report the complete genomic organization and expression profile of the three human WAVE genes and their mouse orthologs. We show that the WAVE genes have distinctive expression patterns in both adult and fetal human and mouse tissues. We also show a high level of conservation between these genes, in both the nucleotide and protein sequences. We finally show that the genomic structure is highly conserved among these genes and that the mouse Wave genes map to chromosome regions that have synteny in the human genome. The gene content in these syntenic regions is also conserved, suggesting that the WAVE genes are derived from a common ancient ancestor by genome duplication. The genomic characterization and expression analysis of the WAVE genes provide the basis towards understanding the function of these genes. It also provides the first steps towards the development of mouse models for the role of the WAVE genes in actin and cytoskeleton organization in general, and in the development of neuroblastoma in particular.
- 1 May 2003
- Published by Springer Nature in Mammalian Genome
- Vol. 14 (5) , 314-322
Genomic organization and expression profile of the human and mouse WAVE gene family
The WAVE gene family, which contains three members, has been shown to play a major role in the actin polymerization and cytoskeleton organization processes. We have identified the WAVE3 gene from Chromosome (Chr) 13q12, as being involved in one of the breakpoints of a t(1:13)(q21:q12) reciprocal translocation, in a patient with ganglioneuroblastoma (Sossey-Alaoui et al. 2002; Oncogene 21: 5967–5974). We have also reported the cloning of the mouse Wave3. During our analysis of the human gene map, we also noted that WAVE2 maps to Chr region lp35-36, which frequently undergoes loss of heterozygosity and deletion in advanced stage neuroblastoma. These data clearly indicate a possible involvement of the WAVE genes in the pathogenesis of neuroblastoma. In this study, we report the complete genomic organization and expression profile of the three human WAVE genes and their mouse orthologs. We show that the WAVE genes have distinctive expression patterns in both adult and fetal human and mouse tissues. We also show a high level of conservation between these genes, in both the nucleotide and protein sequences. We finally show that the genomic structure is highly conserved among these genes and that the mouse Wave genes map to chromosome regions that have synteny in the human genome. The gene content in these syntenic regions is also conserved, suggesting that the WAVE genes are derived from a common ancient ancestor by genome duplication. The genomic characterization and expression analysis of the WAVE genes provide the basis towards understanding the function of these genes. It also provides the first steps towards the development of mouse models for the role of the WAVE genes in actin and cytoskeleton organization in general, and in the development of neuroblastoma in particular.